-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Sign up for news updates
-
Patient, Provider Safety Paramount During Pandemic: Telehealth Benefits Are Numerous
By Mary Jo Fidler, MD Posted: June 10, 2020 Healthcare systems in the United States have been slow to adopt telehealth, in part, due to regulatory limitations, patient privacy concerns, and less reimbursement potential.1 However, at the same time, there has been an enormous effort to incorporate electronic health records (EHR) driven by programs…
-
SHAWL: Largest Study of Its Kind Evaluates Sexual Dysfunction in Women With Lung Cancer
By Narjust Duma, MD Posted: July 31, 2020 In the past 10 years, we have seen significant progress in the treatment options for patients with NSCLC and SCLC, improving OS and quality of life. Thanks to those advances, lung cancer survivorship is a reality, and every day, more survivors are living full lives while receiving…
-
Global Warming, COVID-19, and Lung Cancer: Why Lung Cancer Doctors Should Care About Climate Change
By Joan H. Schiller, MD Posted: August 13, 2020 The COVID-19 pandemic burst upon the world stage with startling force at the beginning of this year. The issues of climate change and global warming have been around somewhat longer—decades, in fact—but are only coming slowly to the public’s attention. What do these two events have…
-
TERAVOLT: Global Registry Investigates Outcomes Among Patients With Thoracic Cancer and COVID-19
By Marina Chiara Garassino, MD, and Leora Horn, MD, MSc, FRCPC Posted: June 9, 2020 Marina Chiara Garassino Leora Horn The new SARS-CoV-2 (COVID-19) virus appeared at the end of December 2019 in Wuhan, China, and soon spread globally. In February 2020, the first cases appeared in Europe, and in…
-
Telehealth Successes and Challenges
Posted: June 9, 2020 Across specialties, COVID-19 has resulted in increased patient anxiety and decreased in-person appointments. The rapid uptake of telehealth has, for some, widened disparity gaps and been an obstacle in maintaining patient–physician relationships; for others, telehealth has presented an opportunity to provide consistent long-term care to patients in the safety and comfort…
-
Making Mesothelioma Patient Research Happen: The United Kingdom Experience
By Liz Darlison, MBE, EN, RN, BSc, MSc; Clare Gardiner, PhD, BSc (hons); Catherine Henshall, MN, RN, MA, PhD; and Angela M. Tod, PhD, MSc, MMedSci, BA (hons), RN Posted: June 9, 2020 The United Kingdom has the highest incidence of mesothelioma in the world. More than 2,700 people in the United Kingdom are diagnosed…
-
Member Story: Dr. Noemi Reguart
Dr. Noemi Reguart is a medical oncologist at the Hospital Clínic in Barcelona, Spain. In Spain, these past few weeks have been difficult—especially for health care personnel. The coronavirus took off fast, and we had very little time to prepare. Luckily, the government implemented the state of alarm quickly, and after 51 days of confinement,…
-
Impact of COVID-19 on the Diagnostic Workup of Lung Cancer
The COVID-19 pandemic has created numerous challenges with the management of lung cancer, not the least of which is the initial diagnosis. The computer tomography scans, typically used in the diagnostic workup, can be obfuscated by the COVID-19 radiologic features therefore this webinar will discuss the best practices on how to distinguish the two. Bronchoscopic…
-
Systemic Therapy for Advanced Stage Lung Cancer During the COVID-19 Pandemic
Watch Recording IASLC faculty members from Europe, Asia and North America will discuss systemic therapies including chemotherapy, immunotherapy, and targeted therapy for advanced-stage lung cancer during the COVID-19 global pandemic. The faculty will share their experience and advice on 1) how COVID-19 impacts their patient population, 2) changes made in the management of current and…
-
Impact of COVID-19 on Treatment of Lung Cancer Patients with Local or Locoregional Disease
Watch Recording This webinar, “Impact of COVID-19 on Treatment of Lung Cancer Patients with Local or Locoregional Disease,” will be presented by IASLC surgical and radiation oncology experts. Faculty will address topics such as postponing surgery and/or radiation depending on the patient’s SARS-CoV-2 status; post-surgery discharge time; operating suite preparation for a SARS-CoV-2 positive patient;…
View ILCN Archives
Provider Resources
Popular Articles